Research graph
References from Multimodal Machine Learning–Based Clinical and Genomic Prognostic Factors for Progression-Free Survival in Metastatic Breast Cancer Using Phase III MONALEESA Trials. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21863
10.3322/caac.21863 · External reference
10.3322/caac.70043
10.3322/caac.70043 · External reference
10.3322/caac.21777
10.3322/caac.21777 · External reference
10.6004/jnccn.2025.0053
10.6004/jnccn.2025.0053 · External reference
10.1056/nejmoa2114663
10.1056/nejmoa2114663 · External reference
10.1056/nejmoa1911149
10.1056/nejmoa1911149 · External reference
10.1056/nejmoa1903765
10.1056/nejmoa1903765 · External reference
Unresolved reference
External reference
10.1158/1078-0432.ccr-17-2369
10.1158/1078-0432.ccr-17-2369 · External reference
Prognostic factors in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a systematic literature review
10.2147/cmar.s300869 · 2021 · External reference
10.1016/s0895-4356(98)00138-3
10.1016/s0895-4356(98)00138-3 · External reference
10.1038/s41598-022-12699-z
10.1038/s41598-022-12699-z · External reference
10.1038/s41416-019-0686-0
10.1038/s41416-019-0686-0 · External reference
10.1186/s12911-020-1043-1
10.1186/s12911-020-1043-1 · External reference
Artificial intelligence-based evaluation of prognostic benefits from immunotherapy plus targeted therapy with or without radiotherapy or TACE in advanced hepatocellular carcinoma
10.3389/fonc.2025.1694565 · 2025 · External reference
10.1038/s41746-022-00613-w
10.1038/s41746-022-00613-w · External reference
Machine learning and deep learning to improve overall survival prediction in cervical cancer patients
10.21037/tcr-2024-2304 · 2025 · External reference
Development and validation of an AI-augmented deep learning model for survival prediction in de novo metastatic colorectal cancer
10.1007/s12672-025-03974-2 · 2025 · External reference
Methodology for good machine learning with multi-omics data
10.1002/cpt.3105 · 2024 · External reference
MONALEESA clinical program: a review of ribociclib use in different clinical settings
10.2217/fon-2019-0130 · 2019 · External reference
10.1056/nejmoa1609709
10.1056/nejmoa1609709 · External reference
10.1200/jco.2018.78.9909
10.1200/jco.2018.78.9909 · External reference
10.1016/s1470-2045(18)30292-4
10.1016/s1470-2045(18)30292-4 · External reference
10.1101/2023.08.30.23294367
10.1101/2023.08.30.23294367 · External reference
Applications of advanced natural language processing for clinical pharmacology
10.1002/cpt.3161 · 2024 · External reference
10.1111/j.1467-9868.2010.00740.x
10.1111/j.1467-9868.2010.00740.x · External reference
TorchSurv: a lightweight package for deep survival analysis
10.21105/joss.07341 · 2024 · External reference
Unresolved reference
External reference
10.1016/s1352-2310(97)00447-0
10.1016/s1352-2310(97)00447-0 · External reference
10.1186/s12874-017-0336-2
10.1186/s12874-017-0336-2 · External reference
Covariate-adjusted log-rank test: guaranteed efficiency gain and universal applicability
10.1093/biomet/asad045 · 2024 · External reference
Unresolved reference
External reference
Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes
10.1111/biom.13377 · 2021 · External reference
Unresolved reference
External reference
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer
10.1016/j.annonc.2025.06.015 · 2025 · External reference
10.1186/s13046-022-02370-w
10.1186/s13046-022-02370-w · External reference
10.3390/ph18020235
10.3390/ph18020235 · External reference
Prognostic value of CtIP/RBBP8 expression in breast cancer
10.1002/cam4.141 · 2013 · External reference
In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis
10.1038/onc.2016.94 · 2016 · External reference
10.3389/fimmu.2022.901784
10.3389/fimmu.2022.901784 · External reference
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
10.1007/s10549-021-06336-y · 2021 · External reference
DLGAP5 regulates the proliferation, migration, invasion, and cell cycle of breast cancer cells via the JAK2/STAT3 signaling axis
10.3390/ijms242115819 · 2023 · External reference
Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer
10.1038/s41523-023-00574-7 · 2023 · External reference
